Portal de investigação
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms (EMPERIAL) - NCT03448406
Dados básicos
Objectivos do projeto
Ensaio Clínico – Iniciativa da Indústria; Fase: III – Aleatorizado; Subtipo: Tratamento – Medicamento; Natureza do Promotor: Indústria Farmacêutica – Tipo comercial; Tipo de Centro: Multicêntrico – Cuidados Secundários – Centro de Ensaio: CHUSJ; Doença investigada: Insuficiência cardíaca – Participantes recrutados: 6
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
A qualitative study of patient and carer experiences with home respiratory therapies: Long-term oxygen therapy and home mechanical ventilation
Caneiras, C; (...); Winck, JC
Article. 10.1016/j.pulmoe.2021.05.010. 2022
Anxiety in heart failure patients and its association with NYHA class
Costa, F; (...); Fernandes, L.
Meeting Abstract. 10.1192/j.eurpsy.2021.503. 2021
Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study
Valdiviesso, R.; (...); Borges, N.
Article. 10.1186/s12872-023-03632-x. 2023
conTemporary reflectiOns regarding heart failure manaGEmenT ? How to ovERcome the PorTuguese barriers (TOGETHER-PT); [Reflex?es contempor?neas sobre a gest?o da insufici?ncia card?aca ? Como ultrapassar as barreiras em Portugal]
Silva Cardoso, J.; (...); Pimenta, J.
Article. 10.1016/j.repc.2023.05.012. 2023
Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study
Sionis, A; (...); Masip, J
Article. 10.1177/0885066619828959. 2020
Effectiveness of Exercise-Based Cardiac Rehabilitation for Heart Transplant Recipients: A Systematic Review and Meta-Analysis
Costa, R; (...); Pinto, R
Review. 10.1177/11786329231161482. 2023
Effectiveness of Tele-rehabilitation Programs in Heart Failure: A Systematic Review and Meta-analysis
Cavalheiro, AH; (...); Azevedo, L.
Review. 10.1177/11786329211021668. 2021
Frailty phenotype and associated nutritional factors in a sample of Portuguese outpatients with heart failure
Valdiviesso, R.; (...); Borges, N.
Article. 10.1016/j.numecd.2021.03.028. 2021
Frailty phenotype in heart failure: A condition that transcends age
Valdiviesso, R; (...); Borges, N
Article. 10.1016/j.repc.2022.02.009. 2023
Global Variations in Heart Failure Etiology, Management, and Outcomes
Joseph, P; (...); Yusuf, S
Article. 10.1001/jama.2023.5942. 2023
Health-Related Quality of Life and Mortality in Heart Failure The Global Congestive Heart Failure Study of 23000 Patients From 40 Countries
Johansson, I; (...); Yusuf, S
Article. 10.1161/CIRCULATIONAHA.120.050850. 2021
Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study
Kataja, A; (...); Harjola, VP
Article. 10.1016/j.ijcard2020.08.069. 2021
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease
Silva Cardoso, J.; (...); Fonseca, C
Article. 10.1007/s10741-020-10069-3. 2021
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study
Hongisto, M; (...); Harjola, VP
Article. 10.1002/ehf2.13224. 2021
Optical Coherence Tomography Imaging of the Lamina Cribrosa: Structural Biomarkers in Nonglaucomatous Diseases
Paulo, A; (...); Barbosa Breda, J.
Article. 10.1155/2021/8844614. 2021
Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper
Silva Cardoso, J.; (...); Brito, D
Article. 10.1016/j.repc.2021.07.009. 2021
Portuguese adaptation of the Chronic Heart Failure Knowledge Questionnaire (KQCHF)
Azzam, AP; (...); Castro, S
Article. 10.1186/s12872-023-03325-5. 2023
Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design - A population-based study
Baptista, R; (...); Gavina, C.
Article. 10.1016/j.repc.2023.10.004. 2023
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease
Rossignol, P; (...); Butler, J
Editorial Material. 10.1016/j.phrs.2022.106277. 2022
Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
Silva Cardoso, J., Moreira, E.
Editorial Material. 10.1016/j.repc.2022.08.006. 2022
SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction
Silva Cardoso, J.; (...); Moura, B
Review. 10.1016/j.repc.2021.02.010. 2021
Socioeconomic Inequalities and Predictors of Cardiac Rehabilitation Referral: Real-World Evidence
Rocha, JA; (...); Cardoso, JCS
Article. 10.1097/PHM.0000000000002270. 2023
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock
Hongisto, M; (...); Network, CSIATG
Article. 10.1093/ehjacc/zuac096. 2022
Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study
Valdiviesso, R.; (...); Borges, N.
Article. 10.1186/s12872-022-02804-5. 2022
The Future of Telemedicine in the Management of Heart Failure Patients
Silva Cardoso, J.; (...); Moreira, E.
Article. 10.15420/cfr.2020.32. 2021
The magnitude of depression in heart failure patients and its association with NYHA class
Botto, J; (...); Fernandes, L.
Meeting Abstract. 10.1192/j.eurpsy.2021.918. 2021
The Portuguese Model of Home Respiratory Care: Healthcare Professionals' Perspective
Caneiras, C; (...); Winck, JC
Article. 10.3390/healthcare9111523. 2021
Time-trends and predictors of interhospital transfers and 30-day rehospitalizations after acute coronary syndrome from 2000-2015
Rocha, JA; (...); Azevedo, L.
Article. 10.1371/journal.pone.0255134. 2021
UNIQUE DEVICE IDENTIFIERS FOR CARDIAC IMPLANTABLE ELECTRONIC DEVICES - A DATA QUALITY ASSESSMENT OF ADMINISTRATIVE HOSPITAL DATA IN PORTUGAL
Couto, S; (...); Freitas, A
Meeting Abstract. 2022
Campos de Estudo
Citação
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms (EMPERIAL) - NCT03448406. (Ensaio Clínico Comercial (EMPERIAL)). Boehringer Ingelheim. 2020IP:José Carlos de Magalhães Silva Cardoso.
